Posttransplant malignancies in solid organ adult recipients: An analysis of the U.S. national transplant database

Transplantation

Volumn 94, Issue 10, 2012, Pages 990-998

  Sampaio, Marcelo Santos ^a   Cho, Yong W ^a,b   Qazi, Yasir ^b   Bunnapradist, Suphamai ^c   Hutchinson, Ian V ^a,b   Shah, Tariq ^a,d  

^a National Institute of Transplantation Los Angeles   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ST VINCENT MEDICAL CENTER   (United States)

Author keywords

Cancer; Posttransplant malignancy; Solid organ transplantation; UNOS

Indexed keywords

TACROLIMUS;

ADULT; ARTICLE; BRONCHUS CANCER; CANCER INCIDENCE; CARDIAC GRAFT REJECTION; CAUCASIAN; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DATA BASE; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; KAPOSI SARCOMA; KIDNEY CANCER; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LUNG CANCER; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PATIENT ASSESSMENT; POPULATION RESEARCH; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; POSTTRANSPLANT MALIGNANCY; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; UNITED STATES;

ADULT; AGED; DATABASES, FACTUAL; FEMALE; HEART TRANSPLANTATION; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84870239085     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318270bc7b     Document Type: Article

References (15)

1. Vajdic CM, McDonald SP, McCredie MR, et al. Cancer incidence before and after kidney transplantation. JAMA 2006; 296: 2823.
2. Martinez OM, de Gruijl FR. Molecular and immunologic mechanisms of cancer pathogenesis in solid organ transplant recipients. Am J Transplant 2008; 8: 2205.
3. Fischer SA, Avery RK. Screening of donor and recipient prior to solid organ transplantation. Am J Transplant 2009; 9(suppl 4): S7.
4. Vajdic CM, van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer 2009; 125: 1747.
5. Ison MG, Hager J, Blumberg E, et al. Donor-derived disease transmission events in the United States: data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee. Am J Transplant 2009; 9: 1929.
6. Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004; 4: 222.
7. Mbulaiteye SM, Engels EA. Kaposi's sarcoma risk among transplant recipients in the United States (1993Y2003). Int J Cancer 2006; 119: 2685.
8. Maisonneuve P, Agodoa L, Gellert R, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999; 354: 93.
9. Stewart JH, Buccianti G, Agodoa L, et al. Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 2003; 14: 197.
10. Kasiske BL, Snyder JJ, Gilbertson DT, et al. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905.
11. Kasiske BL, Kukla A, Thomas D, et al. Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses. Am J Kidney Dis 2011; 58: 971.
12. Engels EA, Pfeiffer RM, Fraumeni JF Jr, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011; 306: 1891.
13. Reddy PN, Sampaio MS, Kuo HT, et al. Impact of pre-existing hepatitis B infection on the outcomes of kidney transplant recipients in the United States. Clin J Am Soc Nephrol 2011; 6: 1481.
14. U.S. Cancer Statistics Working Group. United States cancer statistics: 1999Y2007 Incidence and mortality Web-based report. Available at: http://apps.nccd.cdc.gov/uscs/camcersbyraceandethnicity.aspx. Accessed September 20, 2011.
15. Hocker B, Kovarik JM, Daniel V, et al. Pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on mycophenolate mofetil comedication. Transplantation 2008; 86: 1234.